Monod Bio co-founders, from left: David Shoultz, Daniel-Adriano Silva, and Alfredo Quijano Rubio. (Monod Photo) The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and they also have potential for industrial applications. The origins: Monod’s…
